,66 These findings indicate that FAHD1 may contribute to immunotherapy resistance by shaping an immunosuppressive TME, warranting further investigation into FAHD1-targeted strategies to overcome immunotherapy resistance in HCC. Here, FAHD1 is linked to hepatocellular carcinoma.